Regeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones

昨天

DJ Regeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ rose 2.66% to $618.95 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.74% to 7,553.68 and Dow Jones Industrial Average falling 1.21% to 50,687.07.

This was the stock's second consecutive day of gains.

Regeneron Pharmaceuticals Inc. closed 24.62% below its 52-week high of $821.11, which the company achieved on January 9th.

The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc. $(AMGN)$ rose 3.03% to $338.22, Moderna Inc. (MRNA) rose 7.49% to $49.06, and Gilead Sciences Inc. (GILD) rose 1.11% to $128.99.

Data source: Dow Jones Market Data, FactSet. Data compiled June 3, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

June 03, 2026 16:47 ET (20:47 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2640918493"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2640918493\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2640918493?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-04 04:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2640918493","market":"sh","top_or_hot":-1,"title":"Regeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Regeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Regeneron Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/REGN\">$(REGN)$</a> rose 2.66% to $618.95 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&amp;P 500 Index  falling 0.74% to 7,553.68 and Dow Jones Industrial Average  falling 1.21% to 50,687.07. \n</p>\n<p>\n     This was the stock's second consecutive day of gains. \n</p>\n<p>\n     Regeneron Pharmaceuticals Inc. closed 24.62% below its 52-week high of $821.11, which the company achieved on January 9th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc. <a href=\"https://laohu8.com/S/AMGN\">$(AMGN)$</a> rose 3.03% to $338.22, <a href=\"https://laohu8.com/S/MRNA\">Moderna</a> Inc. (MRNA) rose 7.49% to $49.06, and <a href=\"https://laohu8.com/S/GILD\">Gilead</a> Sciences Inc. (GILD) rose 1.11% to $128.99. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled June 3, 2026. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 03, 2026 16:47 ET (20:47 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2026-06-04 04:47</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ Regeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     Shares of Regeneron Pharmaceuticals Inc. <a href=\"https://laohu8.com/S/REGN\">$(REGN)$</a> rose 2.66% to $618.95 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&amp;P 500 Index  falling 0.74% to 7,553.68 and Dow Jones Industrial Average  falling 1.21% to 50,687.07. \n</p>\n<p>\n     This was the stock's second consecutive day of gains. \n</p>\n<p>\n     Regeneron Pharmaceuticals Inc. closed 24.62% below its 52-week high of $821.11, which the company achieved on January 9th. \n</p>\n<p>\n     The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc. <a href=\"https://laohu8.com/S/AMGN\">$(AMGN)$</a> rose 3.03% to $338.22, <a href=\"https://laohu8.com/S/MRNA\">Moderna</a> Inc. (MRNA) rose 7.49% to $49.06, and <a href=\"https://laohu8.com/S/GILD\">Gilead</a> Sciences Inc. (GILD) rose 1.11% to $128.99. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled June 3, 2026. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  June 03, 2026 16:47 ET (20:47 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"REGN","symbol_name":"再生元製藥公司","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2640918493","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2640918493","pubTimestamp":1780519620,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Regeneron Pharmaceuticals Inc.  rose 2.66% to $618.95 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.74% to 7,553.68 and Dow Jones Industrial Average  falling 1.21% to 50,687.07.This was the stock's second consecutive day of gains.Regeneron Pharmaceuticals Inc. closed 24.62% below its 52-week high of $821.11, which the company achieved on January 9th.The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc.  rose 3.03% to $338.22, Moderna Inc.  rose 7.49% to $49.06, and Gilead Sciences Inc.  rose 1.11% to $128.99.Data source: Dow Jones Market Data, FactSet. Data compiled June 3, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"REGN":"再生元制药公司"},"translate_title":"尽管每日上涨，但与竞争对手相比，再生元制药公司股价周三表现不佳","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"REGN":1.5},"content_text":"DJ Regeneron Pharmaceuticals Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     Shares of Regeneron Pharmaceuticals Inc. $(REGN)$ rose 2.66% to $618.95 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.74% to 7,553.68 and Dow Jones Industrial Average  falling 1.21% to 50,687.07. \n\n\n     This was the stock's second consecutive day of gains. \n\n\n     Regeneron Pharmaceuticals Inc. closed 24.62% below its 52-week high of $821.11, which the company achieved on January 9th. \n\n\n     The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Amgen Inc. $(AMGN)$ rose 3.03% to $338.22, Moderna Inc. (MRNA) rose 7.49% to $49.06, and Gilead Sciences Inc. (GILD) rose 1.11% to $128.99. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled June 3, 2026. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 03, 2026 16:47 ET (20:47 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}